ANXA1 and breast carcinoma: On the other hand, proliferation stimulation was observed in hepatocytes, in which AnxA1 was related to EGF [59], and in breast cancer; in the latter, it was associated with formyl peptide receptor (FPR2) binding and increased levels of cyclin D1 [60].